OMNOVA Solutions Inc. (OMN) Analysts See $0.16 EPS; Royal Bank Of Canada Has Lifted Fresenius Med Care Ag&Co Kga (FMS) Holding By $4.70 Million

January 13, 2018 - By Adrian Erickson

Royal Bank Of Canada increased Fresenius Med Care Ag&Co Kga (FMS) stake by 19.52% reported in 2017Q3 SEC filing. Royal Bank Of Canada acquired 97,950 shares as Fresenius Med Care Ag&Co Kga (FMS)’s stock rose 12.73%. The Royal Bank Of Canada holds 599,644 shares with $29.32M value, up from 501,694 last quarter. Fresenius Med Care Ag&Co Kga now has $33.31 billion valuation. The stock decreased 0.20% or $0.11 during the last trading session, reaching $54.53. About 179,612 shares traded. Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) has risen 11.17% since January 13, 2017 and is uptrending. It has underperformed by 5.53% the S&P500.

Analysts expect OMNOVA Solutions Inc. (NYSE:OMN) to report $0.16 EPS on February, 7.They anticipate $0.02 EPS change or 14.29% from last quarter’s $0.14 EPS. OMN’s profit would be $7.18M giving it 16.72 P/E if the $0.16 EPS is correct. After having $0.25 EPS previously, OMNOVA Solutions Inc.’s analysts see -36.00% EPS growth. The stock increased 0.94% or $0.1 during the last trading session, reaching $10.7. About 99,527 shares traded. OMNOVA Solutions Inc. (NYSE:OMN) has risen 33.59% since January 13, 2017 and is uptrending. It has outperformed by 16.89% the S&P500.




Investors sentiment decreased to 1.11 in 2017 Q3. Its down 0.12, from 1.23 in 2017Q2. It turned negative, as 6 investors sold OMNOVA Solutions Inc. shares while 38 reduced holdings. 13 funds opened positions while 36 raised stakes. 38.61 million shares or 1.15% more from 38.17 million shares in 2017Q2 were reported. Pub Employees Retirement Association Of Colorado accumulated 23,632 shares. Jpmorgan Chase And holds 0% in OMNOVA Solutions Inc. (NYSE:OMN) or 479,400 shares. Synovus invested in 0.03% or 151,927 shares. 925,000 are owned by Gabelli Funds Ltd Co. Pdt Prtnrs Limited Com has 17,700 shares for 0.01% of their portfolio. Barclays Public Limited invested in 25,673 shares. Gsa Prtnrs Llp invested in 0.08% or 105,694 shares. Ubs Asset Management Americas Incorporated invested 0% of its portfolio in OMNOVA Solutions Inc. (NYSE:OMN). Rhumbline Advisers holds 50,273 shares or 0% of its portfolio. Amer Intl Grp Inc invested 0% of its portfolio in OMNOVA Solutions Inc. (NYSE:OMN). Moreover, Tower Research Cap Limited (Trc) has 0% invested in OMNOVA Solutions Inc. (NYSE:OMN) for 5,227 shares. Cornerstone Capital Management Limited Liability holds 0% or 6,900 shares. Tiaa Cref Invest Mngmt Lc has 129,823 shares for 0% of their portfolio. Price T Rowe Md has 0% invested in OMNOVA Solutions Inc. (NYSE:OMN). Ameriprise Inc owns 69,584 shares.

Among 3 analysts covering Omnova Solutions (NYSE:OMN), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Omnova Solutions had 7 analyst reports since September 28, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, August 28 by Jefferies. The stock of OMNOVA Solutions Inc. (NYSE:OMN) has “Buy” rating given on Friday, June 16 by Jefferies. KeyBanc Capital Markets maintained the shares of OMN in report on Thursday, August 24 with “Hold” rating. The stock of OMNOVA Solutions Inc. (NYSE:OMN) has “Buy” rating given on Monday, September 28 by Deutsche Bank. Jefferies maintained OMNOVA Solutions Inc. (NYSE:OMN) rating on Tuesday, October 10. Jefferies has “Buy” rating and $12.0 target. The firm has “Buy” rating by Jefferies given on Tuesday, July 18. KeyBanc Capital Markets maintained the shares of OMN in report on Thursday, September 28 with “Hold” rating.

OMNOVA Solutions Inc. provides emulsion polymers, specialty chemicals, and engineered surfaces for various commercial, industrial, and residential end uses in the United States, Europe, and Asia. The company has market cap of $480.08 million. The firm operates in two divisions, Performance Chemicals and Engineered Surfaces. It currently has negative earnings. The Performance Chemicals segment produces a range of latices, hollow plastic pigments, resins, binders, adhesives, specialty rubbers, antioxidants, and elastomeric modifiers, which are used in gas and oil drilling and production, specialty coatings, paper and packaging, carpet, nonwovens, construction, adhesives, tape, tires, floor care, textiles, graphic arts, polymer stabilization, industrial rubbers and thermoplastics, synthetic gloves, and various other specialty applications.

Among 8 analysts covering Fresenius Medical (NYSE:FMS), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Fresenius Medical had 17 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Sector Perform” rating given on Friday, July 31 by RBC Capital Markets. RBC Capital Markets maintained Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) on Wednesday, July 5 with “Hold” rating. The stock of Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) has “Hold” rating given on Monday, September 11 by RBC Capital Markets. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, October 12. JP Morgan upgraded the stock to “Overweight” rating in Monday, January 4 report. The stock of Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) earned “Hold” rating by Jefferies on Friday, July 8. On Thursday, March 17 the stock rating was initiated by Nomura with “Buy”. RBC Capital Markets maintained Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) on Monday, August 7 with “Hold” rating. Morgan Stanley downgraded Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) on Monday, December 11 to “Equal-Weight” rating. The rating was maintained by RBC Capital Markets with “Sector Perform” on Wednesday, November 4.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: